Retrophin (RTRX) Reports Q1 Loss of $0.04/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Retrophin Reports First Quarter 2015 Financial Results
May 11, 2015 4:06 PM EDTFirst quarter revenues increased 23% sequentially to $17.4 million
Cholbam received FDA approval; launch underway
SAN DIEGO--(BUSINESS WIRE)-- Retrophin, Inc. (NASDAQ: RTRX) today reported its first quarter 2015 financial results.
Net product sales for the first quarter 2015 were $17.4 million Non-GAAP operating income for the first quarter 2015 was $1.4 million, compared to a non-GAAP operating loss of $17.5 million for the same period in 2014 Cash, cash equivalents and marketable securities as of March 31, 2015 totaled $126.3 million... More
